Chicago Clinical Research Institute, Inc | Chicago, IL

Research site

(Unclaimed)

Location

611 W Roosevelt Road, Chicago, Illinois, United States of America

Site insights

Top conditions

Top treatments

Tanezumab

GRT7039

Allopurinol

UBX0101

INDV-6001

Pregabalin

clofutriben

Lorecivivint

Desvenlafaxine

Oxybutynin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 33 total trials

A Study of Dotinurad Versus Allopurinol in Participants With Gout

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol i...

Enrolling

Gout

Drug: Allopurinol

Drug: Dotinurad

A Study of Dotinurad Versus Allopurinol in Tophaceous Gout

The primary objective of this study is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 compared with allopurinol i...

Enrolling

Tophaceous Gout

Drug: Allopurinol

Drug: Dotinurad

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome (Unity)

The main purpose of the proposed study is to evaluate the efficacy of efgartigimod PH20 SC in patients with moderate-to-severe Primary Sjögren's Dise...

Enrolling

Primary Sjogrens Disease

Biological: Efgartigimod PH20 SC

Other: Placebo PH20 SC

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who hav...

Active, not recruiting

Atherosclerotic Cardiovascular Disease (ASCVD)

Elevated Lp(a)

Drug: Lepodisiran Sodium

Drug: Placebo

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a...

Enrolling

COVID-19

SARS-COV-2 Infection

Biological: Placebo

Biological: BNT162b2 Vaccine

INDV-6001 Multiple-Dose Pharmacokinetic Study

This is a multicentre, open-label, multiple dose study of INDV-6001 in adult participants with moderate or severe OUD as defined by the Diagnostic an...

Active, not recruiting

Moderate to Severe Opioid Use Disorder

Drug: Suboxone

Drug: INDV-6001

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial...

Enrolling

Type 2 Diabetes

Cortisol Excess

Drug: clofutriben

Drug: Placebo